References analysis of the Wikipedia article "S100A1" in the English version

doi.org (Global: 2^nd place; English: 2^nd place)

Morii K, Tanaka R, Takahashi Y, Minoshima S, Fukuyama R, Shimizu N, et al. (February 1991). "Structure and chromosome assignment of human S100 alpha and beta subunit genes". Biochemical and Biophysical Research Communications. 175 (1): 185–191. Bibcode:1991BBRC..175..185M. doi:10.1016/S0006-291X(05)81218-5. PMID 1998503.

Engelkamp D, Schäfer BW, Erne P, Heizmann CW (October 1992). "S100 alpha, CAPL, and CACY: molecular cloning and expression analysis of three calcium-binding proteins from human heart". Biochemistry. 31 (42): 10258–10264. doi:10.1021/bi00157a012. PMID 1384693.

Maco B, Mandinova A, Dürrenberger MB, Schäfer BW, Uhrík B, Heizmann CW (2001). "Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart". Physiological Research. 50 (6): 567–574. doi:10.33549/physiolres.930109. PMID 11829317.

Marenholz I, Heizmann CW, Fritz G (October 2004). "S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)". Biochemical and Biophysical Research Communications. 322 (4): 1111–1122. Bibcode:2004BBRC..322.1111M. doi:10.1016/j.bbrc.2004.07.096. PMID 15336958.

Wright N, Cannon B, Zimmer D, Weber D (1 May 2009). "S100A1: Structure, Function, and Therapeutic Potential". Current Chemical Biology. 3 (2): 138–145. doi:10.2174/2212796810903020138. PMC 2771873. PMID 19890475.

Lenarčič Živković M, Zaręba-Kozioł M, Zhukova L, Poznański J, Zhukov I, Wysłouch-Cieszyńska A (23 November 2012). "Post-translational S-nitrosylation is an endogenous factor fine tuning the properties of human S100A1 protein". The Journal of Biological Chemistry. 287 (48): 40457–40470. doi:10.1074/jbc.m112.418392. PMC 3504761. PMID 22989881.

Nowakowski M, Jaremko Ł, Jaremko M, Zhukov I, Belczyk A, Bierzyński A, et al. (May 2011). "Solution NMR structure and dynamics of human apo-S100A1 protein". Journal of Structural Biology. 174 (2): 391–399. doi:10.1016/j.jsb.2011.01.011. PMID 21296671.

Baksheeva VE, Roman AY, Villard C, Devred F, Byrne D, Yatoui D, et al. (December 2021). "Mechanism of Zn²⁺ and Ca²⁺ Binding to Human S100A1". Biomolecules. 11 (12): 1823. doi:10.3390/biom11121823. PMC 8699212. PMID 34944467.

Kiewitz R, Lyons GE, Schäfer BW, Heizmann CW (December 2000). "Transcriptional regulation of S100A1 and expression during mouse heart development". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1498 (2–3): 207–219. doi:10.1016/s0167-4889(00)00097-5. PMID 11108964.

Most P, Remppis A, Pleger ST, Löffler E, Ehlermann P, Bernotat J, et al. (September 2003). "Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance". The Journal of Biological Chemistry. 278 (36): 33809–33817. doi:10.1074/jbc.M301788200. PMID 12777394.

Remppis A, Most P, Löffler E, Ehlermann P, Bernotat J, Pleger S, et al. (2002). "The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes". Basic Research in Cardiology. 97 Suppl 1 (7): I56–I62. doi:10.1007/s003950200031. PMID 12479236. S2CID 25461816.

Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, Börries M, et al. (November 2001). "S100A1: a regulator of myocardial contractility". Proceedings of the National Academy of Sciences of the United States of America. 98 (24): 13889–13894. Bibcode:2001PNAS...9813889M. doi:10.1073/pnas.241393598. PMC 61137. PMID 11717446.

Kettlewell S, Most P, Currie S, Koch WJ, Smith GL (December 2005). "S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes". Journal of Molecular and Cellular Cardiology. 39 (6): 900–910. doi:10.1016/j.yjmcc.2005.06.018. PMID 16236309.

Völkers M, Loughrey CM, Macquaide N, Remppis A, DeGeorge BR, Wegner FV, et al. (February 2007). "S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes". Cell Calcium. 41 (2): 135–143. doi:10.1016/j.ceca.2006.06.001. PMID 16919727.

Reppel M, Sasse P, Piekorz R, Tang M, Roell W, Duan Y, et al. (October 2005). "S100A1 enhances the L-type Ca2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytes". The Journal of Biological Chemistry. 280 (43): 36019–36028. doi:10.1074/jbc.M504750200. PMID 16129693.

Yamasaki R, Berri M, Wu Y, Trombitás K, McNabb M, Kellermayer MS, et al. (October 2001). "Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1". Biophysical Journal. 81 (4): 2297–2313. Bibcode:2001BpJ....81.2297Y. doi:10.1016/S0006-3495(01)75876-6. PMC 1301700. PMID 11566799.

Fukushima H, Chung C, Granzier H (2010). "Titin-isoform dependence of titin-actin interaction and its regulation by S100A1/Ca2+ in skinned myocardium". Journal of Biomedicine & Biotechnology. 2010 727239. doi:10.1155/2010/727239. PMC 2855102. PMID 20414336.

Du XJ, Cole TJ, Tenis N, Gao XM, Köntgen F, Kemp BE, et al. (April 2002). "Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice". Molecular and Cellular Biology. 22 (8): 2821–2829. doi:10.1128/mcb.22.8.2821-2829.2002. PMC 133731. PMID 11909974.

Ehlermann P, Remppis A, Guddat O, Weimann J, Schnabel PA, Motsch J, et al. (February 2000). "Right ventricular upregulation of the Ca(2+) binding protein S100A1 in chronic pulmonary hypertension". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1500 (2): 249–255. doi:10.1016/s0925-4439(99)00106-4. PMID 10657594.

Zimmer DB, Chessher J, Wilson GL, Zimmer WE (December 1997). "S100A1 and S100B expression and target proteins in type I diabetes". Endocrinology. 138 (12): 5176–5183. doi:10.1210/endo.138.12.5579. PMID 9389498.

Tsoporis JN, Marks A, Zimmer DB, McMahon C, Parker TG (January 2003). "The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart". Molecular and Cellular Biochemistry. 242 (1–2): 27–33. doi:10.1023/A:1021148503861. PMID 12619862. S2CID 12957638.

Remppis A, Greten T, Schäfer B, Hunziker P, Erne P, Katus H, et al. (11 October 1996). "Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1313 (3): 253–257. doi:10.1016/0167-4889(96)00097-3. PMID 8898862.

Bennett M, Sweet W, Baicker-McKee S, Looney E, Karohl K, Mountis M, et al. (July 2014). "S100A1 in human heart failure: lack of recovery following left ventricular assist device support". Circulation: Heart Failure. 7 (4): 612–618. doi:10.1161/circheartfailure.113.000849. PMC 4102621. PMID 24842913.

Descamps B, Madeddu P, Emanueli C (4 January 2013). "S100A1: A novel and essential molecular component for postischemic angiogenesis". Circulation Research. 112 (1): 3–5. doi:10.1161/circresaha.112.281022. PMC 3616364. PMID 23287450.

Most P, Lerchenmüller C, Rengo G, Mahlmann A, Ritterhoff J, Rohde D, et al. (4 January 2013). "S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation". Circulation Research. 112 (1): 66–78. doi:10.1161/circresaha.112.275156. PMC 3760372. PMID 23048072.

Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, et al. (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–676. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971. S2CID 24698373.

Most P, Pleger ST, Völkers M, Heidt B, Boerries M, Weichenhan D, et al. (December 2004). "Cardiac adenoviral S100A1 gene delivery rescues failing myocardium". The Journal of Clinical Investigation. 114 (11): 1550–1563. doi:10.1172/JCI21454. PMC 529280. PMID 15578088.

Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, et al. (December 2005). "S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction". Molecular Therapy. 12 (6): 1120–1129. doi:10.1016/j.ymthe.2005.08.002. PMID 16168714.

Most P, Seifert H, Gao E, Funakoshi H, Völkers M, Heierhorst J, et al. (September 2006). "Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction". Circulation. 114 (12): 1258–1268. doi:10.1161/CIRCULATIONAHA.106.622415. PMID 16952982.

Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, et al. (May 2007). "Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue". Circulation. 115 (19): 2506–2515. doi:10.1161/CIRCULATIONAHA.106.671701. PMID 17470693.

Remppis A, Pleger S, Most P, Lindenkamp J, Ehlermann P, Schweda C, et al. (April 2004). "S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts". The Journal of Gene Medicine. 6 (4): 387–394. doi:10.1002/jgm.513. PMID 15079813. S2CID 30629576.

Kiewitz R, Acklin C, Minder E, Huber P, Schäfer B, Heizmann C (11 August 2000). "S100A1, a new marker for acute myocardial ischemia". Biochemical and Biophysical Research Communications. 274 (3): 865–871. Bibcode:2000BBRC..274..865K. doi:10.1006/bbrc.2000.3229. PMID 10924368.

Rohde D, Schön C, Boerries M, Didrihsone I, Ritterhoff J, Kubatzky K, et al. (15 May 2014). "S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4". EMBO Molecular Medicine. 6 (6): 778–794. doi:10.15252/emmm.201303498. PMC 4203355. PMID 24833748.

Most P, Boerries M, Eicher C, Schweda C, Ehlermann P, Pleger S, et al. (28 November 2003). "Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)". The Journal of Biological Chemistry. 278 (48): 48404–48412. doi:10.1074/jbc.m308587200. PMID 12960148.

Matheis G, Abdel-Rahman U, Braun S, Wimmer-Greinecker G, Esmaili A, Seitz U, et al. (October 2000). "Uncontrolled reoxygenation by initiating cardiopulmonary bypass is associated with higher protein S100 in cyanotic versus acyanotic patients". The Thoracic and Cardiovascular Surgeon. 48 (5): 263–268. doi:10.1055/s-2000-7879. PMID 11100757. S2CID 260335126.

Brett W, Mandinova A, Remppis A, Sauder U, Rüter F, Heizmann C, et al. (15 June 2001). "Translocation of S100A1(1) calcium binding protein during heart surgery". Biochemical and Biophysical Research Communications. 284 (3): 698–703. Bibcode:2001BBRC..284..698B. doi:10.1006/bbrc.2001.4996. PMID 11396958.

Brinks H, Rohde D, Voelkers M, Qiu G, Pleger S, Herzog N, et al. (23 August 2011). "S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes". Journal of the American College of Cardiology. 58 (9): 966–973. doi:10.1016/j.jacc.2011.03.054. PMC 3919460. PMID 21851887.

Pleger S, Shan C, Ksienzyk J, Bekeredjian R, Boekstegers P, Hinkel R, et al. (20 July 2011). "Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model". Science Translational Medicine. 3 (92): 92ra64. doi:10.1126/scitranslmed.3002097. PMC 4095769. PMID 21775667.

Belmonte S, Margulies K, Blaxall B (23 August 2011). "S100A1: Another Step Toward Therapeutic Development for Heart Failure". Journal of the American College of Cardiology. 58 (9): 974–976. doi:10.1016/j.jacc.2011.04.032. PMID 21851888.

Rohde D, Brinks H, Ritterhoff J, Qui G, Ren S, Most P (May 2011). "S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials". Journal of Molecular and Cellular Cardiology. 50 (5): 777–784. doi:10.1016/j.yjmcc.2010.08.012. PMID 20732326.

Rohde D, Ritterhoff J, Voelkers M, Katus H, Parker T, Most P (October 2010). "S100A1: a multifaceted therapeutic target in cardiovascular disease". Journal of Cardiovascular Translational Research. 3 (5): 525–537. doi:10.1007/s12265-010-9211-9. PMC 2933808. PMID 20645037.

Kraus C, Rohde D, Weidenhammer C, Qiu G, Pleger S, Voelkers M, et al. (October 2009). "S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy". Journal of Molecular and Cellular Cardiology. 47 (4): 445–455. doi:10.1016/j.yjmcc.2009.06.003. PMC 2739260. PMID 19538970.

Ritterhoff J, Most P (June 2012). "Targeting S100A1 in heart failure". Gene Therapy. 19 (6): 613–621. doi:10.1038/gt.2012.8. PMID 22336719. S2CID 22951165.

Kairouz V, Lipskaia L, Hajjar R, Chemaly E (April 2012). "Molecular targets in heart failure gene therapy: current controversies and translational perspectives". Annals of the New York Academy of Sciences. 1254 (1): 42–50. Bibcode:2012NYASA1254...42K. doi:10.1111/j.1749-6632.2012.06520.x. PMC 3470446. PMID 22548568.

Zouein F, Booz G (2013). "AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling". F1000Prime Reports. 5: 27. doi:10.12703/p5-27. PMC 3732072. PMID 23967378.

Landar A, Caddell G, Chessher J, Zimmer DB (September 1996). "Identification of an S100A1/S100B target protein: phosphoglucomutase". Cell Calcium. 20 (3): 279–285. doi:10.1016/S0143-4160(96)90033-0. PMID 8894274.

Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, et al. (October 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–1178. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514. S2CID 4427026.

Deloulme JC, Assard N, Mbele GO, Mangin C, Kuwano R, Baudier J (November 2000). "S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo". The Journal of Biological Chemistry. 275 (45): 35302–35310. doi:10.1074/jbc.M003943200. PMID 10913138.

Yang Q, O'Hanlon D, Heizmann CW, Marks A (February 1999). "Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma". Experimental Cell Research. 246 (2): 501–509. doi:10.1006/excr.1998.4314. PMID 9925766.

Wang G, Rudland PS, White MR, Barraclough R (April 2000). "Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1". The Journal of Biological Chemistry. 275 (15): 11141–11146. doi:10.1074/jbc.275.15.11141. PMID 10753920.

Holakovska B, Grycova L, Jirku M, Sulc M, Bumba L, Teisinger J (May 2012). "Calmodulin and S100A1 protein interact with N terminus of TRPM3 channel". The Journal of Biological Chemistry. 287 (20): 16645–16655. doi:10.1074/jbc.M112.350686. PMC 3351314. PMID 22451665.

Wright N, Prosser B, Varney K, Zimmer D, Schneider M, Weber D (26 September 2008). "S100A1 and calmodulin compete for the same binding site on ryanodine receptor". The Journal of Biological Chemistry. 283 (39): 26676–26683. doi:10.1074/jbc.m804432200. PMC 2546546. PMID 18650434.

Prosser B, Hernández-Ochoa E, Schneider M (October 2011). "S100A1 and calmodulin regulation of ryanodine receptor in striated muscle". Cell Calcium. 50 (4): 323–331. doi:10.1016/j.ceca.2011.06.001. PMC 3185186. PMID 21784520.

Kiewitz R, Acklin C, Schäfer BW, Maco B, Uhrík B, Wuytack F, et al. (June 2003). "Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart". Biochemical and Biophysical Research Communications. 306 (2): 550–557. doi:10.1016/s0006-291x(03)00987-2. PMID 12804600.

Most P, Boerries M, Eicher C, Schweda C, Völkers M, Wedel T, et al. (January 2005). "Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes". Journal of Cell Science. 118 (Pt 2): 421–431. doi:10.1242/jcs.01614. PMID 15654019. S2CID 33063596.

Prosser B, Wright N, Hernãndez-Ochoa E, Varney K, Liu Y, Olojo R, et al. (22 February 2008). "S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling". The Journal of Biological Chemistry. 283 (8): 5046–5057. Bibcode:2008JBiCh.283.5046P. doi:10.1074/jbc.m709231200. PMC 4821168. PMID 18089560.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Ritterhoff J, Most P (June 2012). "Targeting S100A1 in heart failure". Gene Therapy. 19 (6): 613–621. doi:10.1038/gt.2012.8. PMID 22336719. S2CID 22951165.

Zouein F, Booz G (2013). "AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling". F1000Prime Reports. 5: 27. doi:10.12703/p5-27. PMC 3732072. PMID 23967378.

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Ritterhoff J, Most P (June 2012). "Targeting S100A1 in heart failure". Gene Therapy. 19 (6): 613–621. doi:10.1038/gt.2012.8. PMID 22336719. S2CID 22951165.

S100A1 (English Wikipedia)

doi.org (Global: 2^nd place; English: 2^nd place)

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

ibb.waw.pl (Global: low place; English: low place)

eprints.ibb.waw.pl

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

S100A1 (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 1,626th place; English: 1,007th place)

May2017.archive.ensembl.org

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

ibb.waw.pl (Global: low place; English: low place)

eprints.ibb.waw.pl

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

doi.org (Global: 2^nd place; English: 2^nd place)

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

harvard.edu (Global: 18^th place; English: 17^th place)

nih.gov (Global: 4^th place; English: 4^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)